Penn Medicine researchers have found that patients who respond well to T-cell therapy have an existing supply of “memory” T cells, which support the immune system. Joseph Fraietta of the Perelman School of Medicine, who authored the study, said that the study’s findings may pave the way for the creation of synthetic memory T cells through genetic engineering.